Planet Briefing

First published · Last updated

Evaluating the Anticancer and Anti‐Angiogenic Efficacy of Bergaptol in 2D and 3D Tumor Microtissue Models

A Wiley-published journal article reports laboratory evaluation of bergaptol for anticancer and anti-angiogenic effects using two-dimensional and three-dimensional tumor microtissue models. Publication date is 2026-09-01.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
4/10
Geographic reach
1/10
Global importance
2/10
Impact magnitude
2/10
Positivity
6/10
Urgency
1/10

Why it matters

Results are relevant to cancer research and potential therapeutic development.

Sources

Report an issue